About 30 Californian startups joined PI and Mayor of Irvine, Farrah Khan, for a Startups Roundtable event with special guest, the Honorable Dilawar Syed from the U.S. State Department.

PI has partnered with Chicago-based company ASP Health to help them develop and manufacture an innovative sample preparation instrument to enhance cancer diagnostics through more consistent, high quality patient samples.

Planet Innovation is taking another step in providing a safe working environment for on-site staff by introducing voluntary COVID-19 rapid antigen testing at its Australian facility.

Atmo Biosciences, a digital health company that is developing the world’s first ingestible gas-sensing capsule for monitoring gut health, has closed an oversubscribed A$9.6m capital raise.

Planet Innovation has launched a commercial services unit, PI Commercial, to provide our clients with business guidance and expertise from idea through to product launch.

Minister for Industry Support and Recovery, Martin Pakula, and Minister for Innovation, Medical Research and the Digital Economy, Jaala Pulford, visited PI to officially open our state-of-the-art cleanrooms used to manufacture sterile medical consumables for global clients.

Lumos Diagnostics, a PI investee company, has been admitted to the Australian Securities Exchange (ASX) with trading commencing on July 5 after raising $63 million AUD in an Initial Public Offering (IPO).

Prime Minister Scott Morrison and Federal Member for Chisholm Gladys Liu visited Planet Innovation to tour our expanded manufacturing and design facilities, and discuss the recently announced Patent Box tax incentive.

Atmo Biosciences is ramping up manufacture of its third generation gas-sensing capsule at Planet Innovation’s recently opened new medtech manufacturing facility.

Australia’s Minister for Industry, Science and Technology Karen Andrews visited PI to officially open a new medtech manufacturing wing for products and consumables.

Sam Lanyon speaks to the Talking HealthTech podcast about the future of advanced manufacturing and digital health, especially in light of COVID-19.

Sue MacLeman, an experienced and respected leader in Australia’s medtech industry, has joined the Planet Innovation Board as a non-executive director.

Planet Innovation has closed an oversubscribed $9.8 million capital raising to accelerate business growth to meet strong international demand for its manufacturing, product development and digital services.

Planet Innovation has been recognized as a leading example of resilience, innovation and excellence at the 41st Governor of Victoria Export Awards (GOVEAs).

Visus Therapeutics, a company backed by Planet Innovation, has started a clinical development program for a novel eye drop designed to restore the loss of near vision associated with aging.

Silicon Valley start-up LevitasBio has launched the world’s first label-free cell separation platform, the LeviCell™.

Planet Innovation is using SteraMist® to disinfect its office and manufacturing premises to protect onsite manufacturing staff during the COVID-19 pandemic.

Hany Massarany, a renowned leader in the global diagnostics industry, is joining the Planet Innovation Board as a non-executive director.

Atmo Biosciences has been awarded a $620,000 Australian Government grant through the BioMedTech Horizons (BMTH) program.

TOMI Environmental Solutions, a global company specializing in decontamination and disinfection, has selected Planet Innovation to manufacture its SteraMist® range of products used worldwide for infectious disease control, including to help fight the spread of COVID-19.

PI has partnered with Truvian, a healthcare company at the intersection of diagnostics and consumer technology, to develop a new point-of-care blood testing device to make routine health tests more convenient, affordable and actionable for consumers.

PI has welcomed two experienced company leaders to the PI Board, with Jonathan Ling appointed Chairman and Jim Fox joining as a non-executive director.

Atmo Biosciences, a digital health business that provides objective real-time insights into gut health and microbiome function, has raised a further A$2.5 million in an oversubscribed funding round, supplementing an initial seed raise in March 2019.

Planet Innovation co-CEO and co-founder Stuart Elliott described the COVID-19 pandemic as a “wake-up call” for how medical products are sourced, in an interview with ABC Radio.

Cole-Parmer’s new Masterflex® Ismatec® Reglo Digital Pump series, is not so much an evolution, but a revolution of the popular peristaltic pump range.

We are seeking GPs and other healthcare professionals in Victoria, Australia to pilot a new TGA-approved point-of-care test to help differentiate patients with viral from bacterial acute respiratory tract infections.

Seed Health, a US-based microbial sciences company, and Atmo Biosciences, a Planet Innovation early stage venture, have announced a partnership to use Atmo’s ingestible gas-sensing capsule to study the impact of probiotics on the gut microbiome.

IDEX Health & Science has launched the Tridex™ Protein Analyzer, which Planet Innovation helped develop, to measure protein titer directly from a bioreactor in real time.

Planet Innovation is partnering with Melbourne-based start-up Scinogy to manufacture a revolutionary new cell processing system that is being commercialized by global biotechnology company Thermo Fisher Scientific.

Melbourne-based start-up Allume has signed a manufacturing contract with Planet Innovation to produce its innovative solar sharing system, SolShare.

Planet Innovation took home the Good Design Awards’ top gong for medical design for our work on Clever Culture Systems’ APAS Independence instrument, along with a digital design award for Uniting NSW’s Mosaic app.

Lumos Diagnostics and RPS Diagnostics have merged to create a full-service point-of-care diagnostic development company and support the international commercialization of FebriDx.

PI Digital combines a collaborative engagement model with a strong commercial focus to develop customized digital solutions, including for regulated medical environments.

PI has entered into an agreement with Imagion Biosystems, a company dedicated to improving healthcare through the earlier detection of cancer, to develop Imagion’s MagSense instrument technology.

Speaking at an American Chamber of Commerce event, our Co-CEO and Co-founder Stuart Elliott offered insight into three fundamentals that organizations need to get right if they are serious about innovation.

Atmo Biosciences, a Planet Innovation early stage venture, has signed a licensing deal with RMIT University to secure the exclusive worldwide rights to a ground-breaking ingestible gas-sensing capsule.

Lumos Diagnostics is expanding its global footprint after agreeing an ongoing manufacturing deal for a customized lateral flow reader with a California-based life sciences company.

An RMIT University researcher working with PI on technology that can test patients for bleeding or clotting disorders has been awarded more than $650,000 in NHMRC funding.

Planet Innovation has been selected as one of Australia’s Top 20 Businesses of Tomorrow from more than 1,000 applications.

Planet Innovation has joined the judging panel for The Australian Financial Review’s Most Innovative Companies list after dominating the awards for the past six years.